Designation of Business Secret Sample Clauses

Designation of Business Secret. Parties hereby acknowledge and agree that Investigator’s Brochure, Insurance Contract on Clinical Trial Insurance, Clinical Trial Protocol and detailed calculation of per patient financial schedule, (further stated as „Trial Specific Confidential Information“), are deemed as information significant within the meaning of statutory definition of business secret (Section 504 of Act No. 89/2012 Coll., the Civil Code), as universal access to such information may have a substantial impact on economic results and market position of the Sponsor and members of the Sponsor’s group in other EU Member States. Trial Specific Confidential Information are either part of the text of the main Agreement or individual attachments to this Agreement. Institution and Investigator acknowledge that they also deem Trial Specific Confidential Information significant within the meaning of statutory definition of business secret (Section 504 of Act No. 89/2012 Coll., the Civil Code) and undertake to keep such information confidential in accordance with Section 5 hereof.
Sample 1
AutoNDA by SimpleDocs
Designation of Business Secret. Sponsor notes that information in this agreement or in any subsequent Individual Clinical Trial Agreement concerning compensation (Section 4.4 of the Agreement), Payment Schedule (Appendix 1), Investigator’s Brochure, Insurance Contract on Clinical Trial Insurance and Clinical Trial Protocol deems such information significant within the meaning of statutory definition of business secret (Section 504 of Act No. 89/2012 Coll., the Civil 7.8 Označení obchodního tajemství. Zadavatel uvádí, že informace o odměně (článek 4.4 Smlouvy), Platební rozvrh (Příloha č. 1), Brožura Zkoušejícího, Pojistná smlouva o pojištění klinického hodnocení a Protokol klinického hodnocení považuje za informace významné ve smyslu zákonné definice obchodního tajemství (§ 504 zákona č. 89/2012 Sb., občanský zákoník), neboť všeobecný přístup k těmto informacím může mít podstatný dopad na Code), as universal access to such information may have a substantial impact on economic results and market position of Sponsor and members of the Sponsor’s group in other EU Member States. Institution and Investigator confirm that they also deem the information about compensation (Section 4.4 of the Agreement), Payment Schedule (Appendix 1), Investigator’s Brochure, Insurance Contract on Clinical Trial Insurance and Clinical Trial Protocol significant within the meaning of statutory definition of business secret (Section 504 of Act No. 89/2012 Coll., the Civil Code) and undertake to keep such information confidential in accordance with Section 7 hereof. ekonomické výsledky a tržní postavení Zadavatele a členů koncernu Zadavatele v jiných členských zemích EU. Zdravotnické zařízení a Zkoušející potvrzují, že i pro ně jsou informace o odměně (článek 4.4 Smlouvy), Platební rozvrh (Příloha č. 1), Brožura Zkoušejícího, Pojistná smlouva o pojištění klinického hodnocení a Protokol klinického hodnocení informace významné ve smyslu zákonné definice obchodního tajemství (§ 504 zákona č. 89/2012 Sb., občanský zákoník) a zavazují se o těchto informacích zachovávat mlčenlivost v souladu s článkem 7 této Smlouvy.
Sample 1
Designation of Business Secret. Sponsor notes that information concerning compensation (Section 2.4 of the Agreement), Payment Schedule (Appendix 1), Investigator’s Brochure, Insurance Contract on Clinical Trial Insurance and Clinical Trial Protocol deems such information significant within the meaning of statutory definition of business secret (Section 504 of Act No. 89/2012 Coll., the Civil Code), as universal access to such information may have a substantial impact on economic results and market position of Sponsor and members of the Sponsor’s group in other EU Member States. Institution and Investigator confirm that they also deem the information about compensation (Section 2.4 of the Agreement), Payment Schedule (Appendix 1), Investigator’s Brochure, Insurance Contract on Clinical Trial Insurance and Clinical Trial
Sample 1
Designation of Business Secret. Parties hereby acknowledge and agree that Investigator’s Brochure, Insurance Contract on Clinical Trial Insurance, Clinical Trial Protocol and detailed calculation of per study subject financial schedule, (further stated as „Trial Specific Confidential Information“), are deemed as information significant within the meaning of statutory definition of business secret (Section 504 of Act No. 89/2012 Coll., the Civil Code), as universal access to such information may have a substantial impact on economic results and market position of the Sponsor and members of the Sponsor’s group in other EU Member States. Trial Specific Confidential 6. OBCHODNÍ TAJEMSTVÍ 6.1 Označení obchodního tajemství. Smluvní strany berou na vědomí a souhlasí, že Brožura Zkoušejícího, Pojistná smlouva o pojištění klinického hodnocení, Protokol klinického hodnocení stejně jako podrobný výpočet finanční odměny za Subjekt hodnocení (xxxx xxx „Xxxxxxx informace týkající se klinického hodnocení“) považují za informace významné ve smyslu zákonné definice obchodního tajemství (§ 504 zákona č. 89/2012 Sb., občanský zákoník), neboť všeobecný přístup k těmto informacím může mít podstatný dopad na ekonomické výsledky a tržní postavení Zadavatele a členů koncernu Zadavatele v jiných členských zemích
Sample 1

Related to Designation of Business Secret

  • Change in Form of Business Organization If, during the term of this Agreement, the form of CONTRACTOR’s business organization changes, or the ownership of CONTRACTOR changes, or when changes occur between CONTRACTOR and other businesses that could impact services provided through this Agreement, CONTRACTOR shall promptly notify ADMINISTRATOR, in writing, detailing such changes. A change in the form of business organization may, at COUNTY’s sole discretion, be treated as an attempted assignment of rights or delegation of duties of this Agreement.

  • Transfer of Business Where a transfer of business occurs, an Employee who worked with the old employer and who continues in the service of the new employer will be entitled to count her/his service with the old employer as service with the new employer for the purposes of this clause.

  • Operation of Business Each of Borrower and its Subsidiaries possesses all licenses, permits, consents, authorizations, franchises, patents, copyrights, trademarks, and trade names, or rights thereto, necessary to conduct its respective businesses substantially as now conducted and as presently proposed to be conducted, and neither Borrower nor any of its Subsidiaries is in violation of any valid rights of others with respect to any of the foregoing which could result in a Material Adverse Event.

  • Obligations and Activities of Business Associate Business Associate agrees to:

  • Responsibilities of Business Associate Business Associate agrees:

  • Designation of Key Personnel The Contractor’s Contract Manager for this engagement shall be Xxxxxxx Xxxxxxx, Phone: (000) 000-0000, Email Address: xxxxxxx@xxxxxxxxxx.xxx. The City’s Contract Manager for the engagement shall be Xxx Xxxxx, Phone: ( 512 ) 974 - 8211 , Email Address: Xxx.Xxxxx@xxxxxxxxxxx.xxx. The City and the Contractor resolve to keep the same key personnel assigned to this engagement throughout its term. In the event that it becomes necessary for the Contractor to replace any key personnel, the replacement will be an individual having equivalent experience and competence in executing projects such as the one described herein. Additionally, the Contractor will promptly notify the City Contract Manager and obtain approval for the replacement. Such approval shall not be unreasonably withheld.

  • Obligations and Activities of Business Associates (1) Business Associate agrees not to use or disclose PHI other than as permitted or required by this Section of the Contract or as Required by Law.

  • Terms of Business Capitalised terms used in this API Agreement have the meanings given to them in our Terms of Business, unless the context requires otherwise or unless separately defined in this API Agreement. The same rules of interpretation set out in our Terms of Business apply in this API Agreement. If there is any inconsistency between the provisions of the API Agreement and our Agreement, the Terms of Business will prevail unless the provision relates exclusively to your use of our API, in which case API Agreement will prevail. In all other circumstances.

  • Transfer of Records In accordance with Sections 2.1 and 3.1, the Receiver assigns, transfers, conveys and delivers to the Assuming Institution, whether located on Bank Premises occupied or not occupied by the Assuming Institution or at any other location, any and all Records of the Failed Bank, other than the following:

  • Cessation of Business Any Obligor suspends or ceases to carry on (or threatens to suspend or cease to carry on) all or a material part of its business.

Time is Money Join Law Insider Premium to draft better contracts faster.